Impact of obesity and metabolic syndrome on immunity

Advances in Nutrition

Volumn 7, Issue 1, 2016, Pages 66-75

  Andersen, Catherine J ^a   Murphy, Kelsey E ^a   Fernandez, Maria Luz ^b  

^a FAIRFIELD UNIVERSITY   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; IMMUNE SYSTEM; IMMUNOLOGY; LEUKOCYTE; LYMPHOID TISSUE; METABOLIC SYNDROME X; OBESITY; PATHOPHYSIOLOGY;

HUMANS; IMMUNE SYSTEM; LEUKOCYTES; LYMPHOID TISSUE; METABOLIC SYNDROME X; OBESITY;

EID: 85000788380     PISSN: 21618313     EISSN: 21565376     Source Type: Journal    
DOI: 10.3945/an.115.010207     Document Type: Review

References (129)

1. Field AE, Coakley EH, Must A, Spadano JL, Laird N, Dietz WH,Rimm E, Colditz GA. Impact of over weight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med2001;161:1581-6.
2. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
3. Zimmet P, Magliano D, Matsuzawa Y, Alberti G, Shaw J. The metabolic syndrome: a global public health problem and a new definition.J Atheroscler Thromb 2005;12:295-300.
4. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity in the United States, 2009-2010. NCHS Data Brief 2012;82:1-8.
5. Jia H, Lubetkin EI. Trends in quality-adjusted life-years lost contributed by smoking and obesity. Am J Prev Med 2010;38:138-44.
6. Misra A, Khurana L. Obesity and the metabolic syndrome in developing countries. J Clin Endocrinol Metab 2008;93:S9-30.
7. Finkelstein EA, Trogdon JG, Cohen JW, Dietz W. Annual medicals pending attributable to obesity: payer-and service-specific estimates.Health Aff (Millwood) 2009;28:w822-31.
8. Guilherme A, Virbasius JV, Puri V, Czech MP. Adipocyte dys functions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 2008;9:367-77.
9. Huang PL. A comprehensive definition for metabolic syndrome. Dis Model Mech 2009;2:231-7.
10. Ervin RB. Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index:United States, 2003-2006. Natl Health Stat Report 2009;13:1-7.
11. Aguilar M, Bhuket T, Torres S, Liu B, Wong RJ. Prevalence of the metabolic syndrome in the United States, 2003-2012. JAMA 2015;313:1973-4.
12. Kanneganti TD, Dixit VD. Immunological complications of obesity.Nat Immunol 2012;13:707-12.
13. Winer S, Chan Y, Paltser G, Truong D, Tsui H, Bahrami J, Dorfman R,Wang Y, Zielenski J, Mastronardi F, et al. Normalization of obesity associated insulin resistance through immuno therapy. Nat Med 2009;15:921-9.
14. Bremer AA, Jialal I. Adipose tissue dysfunction in nascent metabolic syndrome. J Obes 2013;2013:393192.
15. Bremer AA, Devaraj S, Afify A, Jialal I. Adipose tissue dysregulation inpatients with metabolic syndrome. J Clin Endocrinol Metab 2011;96:E1782-8.
16. Bandaru P, Rajkumar H, Nappanveettil G. The impact of obesity onimmune response to infection and vaccine: an insight into plausible mechanisms. Endocrinol Metab Syndr 2013;2:2.
17. Sheridan PA, Paich HA, Handy J, Karlsson EA, Hudgens MG, SammonAB, Holland LA, Weir S, Noah TL, Beck MA. Obesity is associated with impaired immune response to influenza vaccination in humans. Int JObes (Lond) 2012;36:1072-7.
18. Yang H, Youm YH, Vandanmagsar B, Rood J, Kumar KG, Butler AA,Dixit VD. Obesity accelerates thymic aging. Blood 2009;114:3803-12.
19. Ghanim H, Aljada A, Hofmeyer D, Syed T, Mohanty P, Dandona P.Circulating mononuclear cells in the obese are in a pro inflammatory state. Circulation 2004;110:1564-71.
20. Feuerer M, Herrero L, Cipolletta D, Naaz A, Wong J, Nayer A, Lee J,Goldfine AB, Benoist C, Shoelson S, et al. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med 2009;15:930-9.
21. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010;140:883-99.
22. Iwasaki H, Akashi K. Myeloid lineage commitment from the hematopoietic stem cell. Immunity 2007;26:726-40.
23. Takahama Y. Journey through the thymus: stromal guides for T-cell development and selection. Nat Rev Immunol 2006;6:127-35.
24. Iwasaki A, Medzhitov R. Regulation of adaptive immunity by the innateimmune system. Science 2010;327:291-5.
25. Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dualanti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol2008;8:349-61.
26. Dranoff G. Cytokines in cancer pathogenesis and cancer therapy. Nat Rev Cancer 2004;4:11-22.
27. Eisen HN, Chakraborty AK. Evolving concepts of specificity in immunereactions. Proc Natl Acad Sci USA 2010;107:22373-80.
28. Harrington LE, Janowski KM, Oliver JR, Zajac AJ, Weaver CT. Memory CD4 T cells emerge from effector T-cell progenitors. Nature 2008;452:356-60.
29. McHeyzer-Williams LJ, McHeyzer-Williams MG. Antigen-specific memory B cell development. Annu Rev Immunol 2005;23:487-513.
30. Fazilleau N, McHeyzer-Williams LJ, McHeyzer-Williams MG. Local development of effector and memory T helper cells. Curr Opin Immunol2007;19:259-67.
31. Mogensen TH. Pathogen recognition and inflammatory signaling ininnate immune defenses. Clin Microbiol Rev 2009;22:240-73.
32. Todd DJ, Lee AH, Glimcher LH. The endoplasmic reticulum stress response in immunity and autoimmunity. Nat Rev Immunol 2008;8:663-74.
33. Serhan CN, Savill J. Resolution of inflammation: the beginning programs the end. Nat Immunol 2005;6:1191-7.
34. Medzhitov R. Origin and physiological roles of inflammation. Nature2008;454:428-35.
35. Patel PS, Buras ED, Balasubramanyam A. The role of the immune system in obesity and insulin resistance. J Obes 2013;2013:616193.
36. Rius B, Lopez-Vicario C, Gonzalez-Periz A, Moran-Salvador E,Garcia-Alonso V, Claria J, Titos E. Resolution of inflammation inobesity-induced liver disease. Front Immunol 2012;3:257.
37. Karlsson EA, Sheridan PA, Beck MA. Diet-induced obesity in mice reduces the maintenance of influenza-specific CD8+ memory T cells.J Nutr 2010;140:1691-7.
38. White PJ, Arita M, Taguchi R, Kang JX, Marette A. Transgenic restoration of long-chain n-3 fatty acids in insulin target tissues improves resolution capacity and alleviates obesity-linked inflammation and insulin resistance in high-fat-fed mice. Diabetes 2010;59:3066-73.
39. Bredella MA, Gill CM, Gerweck AV, Landa MG, Kumar V, Daley SM,Torriani M, Miller KK. Ectopic and serum lipid levels are positively associated with bone marrow fat in obesity. Radiology 2013;269:534-41.
40. Cortez M, Carmo LS, Rogero MM, Borelli P, Fock RA. A high-fatdiet increases IL-1, IL-6, and TNF-alpha production by increasing NF-kappaB and attenuating PPAR-gamma expression in bone marrow mesenchymal stem cells. Inflammation 2013;36:379-86.
41. Barbu-Tudoran L, Gavriliuc OI, Paunescu V, Mic FA. Accumulation oftissue macrophages and depletion of resident macrophages in the diabeticthymus in response to hyperglycemia-induced thymocyte apoptosis.J Diabetes Complications 2013;27:114-22.
42. Nagib PR, Gameiro J, Stivanin-Silva LG, de Arruda MS, Villa-VerdeDM, Savino W, Verinaud L. Thymic micro environmental alterations in experimentally induced diabetes. Immunobiology 2010;215:971-9.
43. Howard JK, Lord GM, Matarese G, Vendetti S, Ghatei MA, Ritter MA,Lechler RI, Bloom SR. Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob/ob mice.J Clin Invest 1999;104:1051-9.
44. Weitman ES, Aschen SZ, Farias-Eisner G, Albano N, Cuzzone DA,Ghanta S, Zampell JC, Thorek D, Mehrara BJ. Obesity impairs lymphatic fluid transport and dendritic cell migration to lymph nodes.PLoS One 2013;8:e70703.
45. Naveiras O, Nardi V, Wenzel PL, Hauschka PV, Fahey F, Daley GQ.Bone-marrow adipocytes as negative regulators of the haematopoietic micro environment. Nature 2009;460:259-63.
46. Bennett BD, Solar GP, Yuan JQ, Mathias J, Thomas GR, Matthews W.A role for leptin and its cognate receptor in hematopoiesis. Curr Biol1996;6:1170-80.
47. Yvan-Charvet L, Pagler T, Gautier EL, Avagyan S, Siry RL, Han S,Welch CL, Wang N, Randolph GJ, Snoeck HW, et al. ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation.Science 2010;328:1689-93.
48. Ishizaka N, Ishizaka Y, Toda E, Nagai R, Yamakado M. Association betweencigarette smoking, white blood cell count, and metabolic syndromeas defined by the Japanese criteria. Intern Med 2007;46:1167-70.
49. Oda E, Kawai R. The prevalence of metabolic syndrome and diabetes increases through the quartiles of white blood cell count in Japanese men and women. Intern Med 2009;48:1127-34.
50. Nilsson G, Hedberg P, Jonason T, Lonnberg I, Tenerz A, Ohrvik J.White blood cell counts associate more strongly to the metabolic syndrome in 75-year-old women than in men: a population based study.Metab Syndr Relat Disord 2007;5:359-64.
51. Twig G, Afek A, Shamiss A, Derazne E, Tzur D, Gordon B, Tirosh A.White blood cells count and incidence of type 2 diabetes in young men. Diabetes Care 2013;36:276-82.
52. Chae JS, Paik JK, Kang R, Kim M, Choi Y, Lee SH, Lee JH. Mildweight loss reduces inflammatory cytokines, leukocyte count, and oxidative stress in over weight and moderately obese participants treated for 3 years with dietary modification. Nutr Res 2013;33:195-203.
53. Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 2007;117:175-84.
54. Lumeng CN, Deyoung SM, Bodzin JL, Saltiel AR. Increased inflammatory properties of adipose tissue macrophages recruited duringdiet-induced obesity. Diabetes 2007;56:16-23.
55. Nguyen MT, Favelyukis S, Nguyen AK, Reichart D, Scott PA, Jenn A,Liu-Bryan R, Glass CK, Neels JG, Olefsky JM. A sub population of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways. J Biol Chem 2007;282:35279-92.
56. O'Rourke RW, Kay T, Scholz MH, Diggs B, Jobe BA, Lewinsohn DM,Bakke AC. Alterations in T-cell subset frequency in peripheral blood in obesity. Obes Surg 2005;15:1463-8.
57. van der Weerd K, Dik WA, Schrijver B, Schweitzer DH, Langerak AW,Drexhage HA, Kiewiet RM, van Aken MO, van Huisstede A, van DongenJJ, et al. Morbidly obese human subjects have increased peripheral blood CD4+ T cells with skewing toward a Treg- and Th2-dominatedpheno type. Diabetes 2012;61:401-8.
58. Sheu WH, Chang TM, Lee WJ, Ou HC, Wu CM, Tseng LN, Lang HF,Wu CS, Wan CJ, Lee IT. Effect of weight loss on pro inflammatory state of mononuclear cells in obese women. Obesity (Silver Spring)2008;16:1033-8.
59. Merhi ZO, Durkin HG, Feldman J, Macura J, Rodriguez C, Minkoff H. Effect of bariatric surgery on peripheral blood lymphocyte subsets in women. Surg Obes Relat Dis 2009;5:165-71.
60. Armstrong AJ, Gebre AK, Parks JS, Hedrick CC. ATP-binding cassette transporter G1 negatively regulates thymocyte and peripheral lymphocyteproliferation. J Immunol 2010;184:173-83.
61. Levine DM, Parker TS, Donnelly TM, Walsh A, Rubin AL. In vivoprotection against endotoxin by plasma high density lipoprotein.Proc Natl Acad Sci USA 1993;90:12040-4.
62. Kitchens RL, Thompson PA, Munford RS, O'Keefe GE. Acute inflammation and infection maintain circulating phospholipid levels and enhance lipopolysaccharide binding to plasma lipoproteins. J Lipid Res 2003;44:2339-48.
63. Strandberg L, Verdrengh M, Enge M, Andersson N, Amu S, Onnheim K, Benrick A, Brisslert M, Bylund J, Bokarewa M, et al. Mice chronicallyfed high-fat diet have increased mortality and disturbed immune response in sepsis. PLoS One 2009;4:e7605.
64. Kumar NP, Sridhar R, Banurekha VV, Jawahar MS, Nutman TB, Babu S. Expansion of pathogen-specific T-helper 1 and T-helper 17 cells inpulmonary tuberculosis with coincident type 2 diabetes mellitus. J InfectDis 2013;208:739-48.
65. Teoh H, Quan A, Bang KW, Wang G, Lovren F, Vu V, Haitsma JJ,Szmitko PE, Al-Omran M, Wang CH, et al. Adiponectin deficiency promotes endothelial activation and profoundly exacerbates sepsisrelated mortality. Am J Physiol Endocrinol Metab 2008;295:E658-64.
66. Chandra RK. Cell-mediated immunity in genetically obese C57BL/6J ob/ob) mice. Am J Clin Nutr 1980;33:13-6.
67. Smith AG, Sheridan PA, Tseng RJ, Sheridan JF, Beck MA. Selective impairment in dendritic cell function and altered antigen-specific CD8+T-cell responses in diet-induced obese mice infected with influenza virus.Immunology 2009;126:268-79.
68. Lecube A, Pachon G, Petriz J, Hernandez C, Simo R. Phagocytic activityis impaired in type 2 diabetes mellitus and increases after metabolic improvement. PLoS One 2011;6:e23366.
69. Mori A, Sakurai H, Choo MK, Obi R, Koizumi K, Yoshida C, Shimada Y, Saiki I. Severe pulmonary metastasis in obese and diabetic mice. IntJ Cancer 2006;119:2760-7.
70. Bandaru P, Rajkumar H, Nappanveettil G. Altered or impaired immune response to hepatitis B vaccine in WNIN/GR-Ob rat: an obeserat model with impaired glucose tolerance. ISRN Endocrinol 2011;2011:980105.
71. Ocak S, Eskiocak AF. The evaluation of immune responses to hepatitis B vaccination in diabetic and non-diabetic haemodialysis patients and the use of tetanus toxoid. Nephrology (Carlton) 2008;13:487-91.
72. Eliakim A, Schwindt C, Zaldivar F, Casali P, Cooper DM. Reduced tetanus antibody titers in over weight children. Autoimmunity 2006;39:137-41.
73. Allard R, Leclerc P, Tremblay C, Tannenbaum TN. Diabetes and the severity of pandemic influenza A (H1N1) infection. Diabetes Care2010;33:1491-3.
74. Charland KM, Buckeridge DL,Hoen AG, Berry JG, Elixhauser A, Melton F, Brownstein JS. Relationship between community prevalence of obesity and associated behavioral factors and community rates of influenza related hospitalizations in the United States. Influenza Other Respir Viruses2013;7:718-28.
75. Visness CM, London SJ, Daniels JL, Kaufman JS, Yeatts KB, Siega-RizAM, Liu AH, Calatroni A, Zeldin DC. Association of obesity with IgE levels and allergy symptoms in children and adolescents: results from the National Health and Nutrition Examination Survey 2005-2006.J Allergy Clin Immunol 2009;123:1163-9.
76. Naaz A, Holsberger DR, Iwamoto GA, Nelson A, Kiyokawa H, CookePS. Loss of cyclin-dependent kinase inhibitors produces adipocyte hyperplasia and obesity. FASEB J 2004;18:1925-7.
77. Deng J, Liu S, Zou L, Xu C, Geng B, Xu G. Lipolysis response to endoplasmic reticulum stress in adipose cells. J Biol Chem 2012;287:6240-9.
78. Sartipy P, Loskutoff DJ. Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci USA 2003;100:7265-70.
79. Ferrante AW, Jr. The immune cells in adipose tissue. Diabetes Obes Metab 2013;15(Suppl 3):34-8.
80. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, FerranteAW, Jr. Obesity is associated with macrophage accumulation in adiposetissue. J Clin Invest 2003;112:1796-808.
81. Kraakman MJ, Murphy AJ, Jandeleit-Dahm K, Kammoun HL. Macrophagepolarization in obesity and type 2 diabetes: weighing down our understanding of macrophage function? Front Immunol 2014;5:470.
82. Lagathu C, Yvan-Charvet L, Bastard JP, Maachi M, Quignard-Boulange A, Capeau J, Caron M. Long-term treatment with interleukin-1beta induces insulin resistance in murine and human adipocytes. Diabetologia2006;49:2162-73.
83. Altintas MM, Azad A, Nayer B, Contreras G, Zaias J, Faul C, Reiser J,Nayer A. Mast cells, macrophages, and crown-like structures distinguish subcutaneous from visceral fat in mice. J Lipid Res 2011;52:480-8.
84. de Alvaro C, Teruel T, Hernandez R, Lorenzo M. Tumor necrosis factoralpha produces insulin resistance in skeletal muscle by activation of inhibitor kappaB kinase in a p38 MAPK-dependent manner.J Biol Chem 2004;279:17070-8.
85. Grunfeld C, Gulli R, Moser AH, Gavin LA, Feingold KR. Effect of tumornecrosis factor administration in vivo on lipoprotein lipase activity in various tissues of the rat. J Lipid Res 1989;30:579-85.
86. Zhang HH, Halbleib M, Ahmad F, Manganiello VC, Greenberg AS.Tumor necrosis factor-alpha stimulates lipolysis in differentiated human adipocytes through activation of extracellular signal-relatedkinase and elevation of intracellular cAMP. Diabetes 2002;51:2929-35.
87. Bézaire V, Mairal A, Anesia R, Lefort C, Langin D. Chronic TNFalphaand cAMP pre-treatment of human adipocytes alter HSL, ATGL andperilipin to regulate basal and stimulated lipolysis. FEBS Lett 2009;583:3045-9.
88. Norseen J, Hosooka T, Hammarstedt A, Yore MM, Kant S, Aryal P,Kiernan UA, Phillips DA, Maruyama H, Kraus BJ, et al. Retinol-binding protein 4 inhibits insulin signaling in adipocytes by inducing proinflammatory cytokines in macrophages through a c-Jun N-terminal kinaseandtoll-like receptor 4-dependent and retinol-independent mechanism.Mol Cell Biol 2012;32:2010-9.
89. Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM,Kotani K, Quadro L, Kahn BB. Serum retinol binding protein 4 contributesto insulin resistance in obesity and type 2 diabetes. Nature2005;436:356-62.
90. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 2006;116:1784-92.
91. Scarpace PJ, Zhang Y. Leptin resistance: a prediposing factor for diet induced obesity. Am J Physiol Regul Integr Comp Physiol 2009;296:R493-500.
92. Strissel KJ, DeFuria J, Shaul ME, Bennett G, Greenberg AS, Obin MS.T-cell recruitment and Th1 polarization in adipose tissue during diet induced obesity in C57BL/6 mice. Obesity (Silver Spring) 2010;18:1918-25.
93. Yang H, Youm YH, Vandanmagsar B, Ravussin A, Gimble JM, Greenway F, Stephens JM, Mynatt RL, Dixit VD. Obesity increases the production of proinflammatory mediators from adipose tissue T cells and compromises TCR repertoire diversity: implications for systemic inflammation and insulin resistance. J Immunol 2010;185:1836-45.
94. Yang H, Youm YH, Dixit VD. Inhibition of thymic adipogenesis by caloricrestriction is coupled with reduction in age-related thymic involution.J Immunol 2009;183:3040-52.
95. Kim CS, Lee SC, Kim YM, Kim BS, Choi HS, Kawada T, Kwon BS, Yu R. Visceral fat accumulation induced by a high-fat diet causes the a trophy of mesenteric lymph nodes in obese mice. Obesity (Silver Spring) 2008;16:1261-9.
96. Dixit VD. Impact of immune-metabolic interactions on age-related thymic demise and T cell senescence. Semin Immunol 2012;24:321-30.
97. Ley K, Kansas GS. Selectins in T-cell recruitment to non-lymphoid tissues and sites of inflammation. Nat Rev Immunol 2004;4:325-35.
98. Morrison SJ, Scadden DT. The bone marrow niche for haematopoieticstem cells. Nature 2014;505:327-34.
99. Dixit VD. Adipose-immune interactions during obesity and caloric restriction:reciprocal mechanisms regulating immunity and healths pan. J Leukoc Biol 2008;84:882-92.
100. Castelo-Branco C, Soveral I. The immune system and aging: a review.Gynecol Endocrinol 2014;30:16-22.
101. Colman RJ, Beasley TM, Kemnitz JW, Johnson SC, Weindruch R,Anderson RM. Caloric restriction reduces age-related and all-causemortality in rhesus monkeys. Nat Commun 2014;5:3557.
102. Feingold KR, Grunfeld C. The role of HDL in innate immunity.J Lipid Res 2011;52:1-3.
103. Mora S, Glynn RJ, Ridker PM. High-density lipoprotein cholesterol,size, particle number, and residual vascular risk after potent stat in therapy. Circulation 2013;128:1189-97.
104. Andersen CJ, Fernandez ML. Dietary approaches to improving at hero protective HDL functions. Food Funct 2013;4:1304-13.
105. Kontush A, Chapman MJ. Functionally defective high-density lipoprotein:a new therapeutic target at the crossroads of dyslipidemia, inflammation,and atherosclerosis. Pharmacol Rev 2006;58:342-74.
106. Zhao Y, Van Berkel TJ, Van Eck M. Relative roles of various efflux pathways in net cholesterol efflux from macrophage foam cells in atheroscleroticlesions. Curr Opin Lipidol 2010;21:441-53.
107. Kellner-Weibel G, de la Llera-Moya M. Update on HDL receptors and cellular cholesterol transport. Curr Atheroscler Rep 2011;13:233-41.
108. Hansson GK, Bjorkholm M. Medicine. Tackling two diseases with HDL. Science 2010;328:1641-2.
109. Feldman DL, Mogelesky TC, Liptak BF, Gerrity RG. Leukocytosis in rabbits with diet-induced atherosclerosis. Arterioscler Thromb 1991;11:985-94.
110. Park BS, Song DH, Kim HM, Choi BS, Lee H, Lee JO. The structuralbasis of lipopolysaccharide recognition by the TLR4-MD-2 complex.Nature 2009;458:1191-5.
111. Soehnlein O, Lindbom L. Phagocyte partnership during the onset and resolution of inflammation. Nat Rev Immunol 2010;10:427-39.
112. Read TE, Harris HW, Grunfeld C, Feingold KR, Calhoun MC, KaneJP, Rapp JH. Chylomicrons enhance endotoxin excretion in bile. Infect Immun 1993;61:3496-502.
113. Zhu X, Parks JS. New roles of HDL in inflammation and hematopoiesis.Annu Rev Nutr 2012;32:161-82.
114. Creely SJ, McTernan PG, Kusminski CM, Fisher FM, Da Silva NF,Khanolkar M, Evans M, Harte AL, Kumar S. Lipopolysaccharide activates an innate immune system response in human adipose tissue inobesity and type 2 diabetes. Am J Physiol Endocrinol Metab 2007;292:E740-7.
115. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, NeyrinckAM, Fava F, Tuohy KM, Chabo C, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007;56:1761-72.
116. Pedersen R, Andersen AD, Hermann-Bank ML, Stagsted J, Boye M.The effect of high-fat diet on the composition of the gut microbiotain cloned and non-cloned pigs of lean and obese phenotype. GutMicrobes 2013;4:371-81.
117. Bervoets L, Van Hoorenbeeck K, Kortleven I, Van Noten C, Hens N,Vael C, Goossens H, Desager KN, Vankerckhoven V. Differences in gut microbiota composition between obese and lean children: a crosssectional study. Gut Pathog 2013;5:10.
118. Delzenne NM, Neyrinck AM, Cani PD. Modulation of the gut microbiotaby nutrients with prebiotic properties: consequences for host health in the context of obesity and metabolic syndrome. MicrobCell Fact 2011;10(Suppl 1):S10.
119. Vreugdenhil AC, Rousseau CH, Hartung T, Greve JW, van 't Veer C,Buurman WA. Lipopolysaccharide (LPS)-binding protein mediates LPS detoxification by chylomicrons. J Immunol 2003;170:1399-405.
120. Hansel B, Giral P, Nobecourt E, Chantepie S, Bruckert E, ChapmanMJ, Kontush A. Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. J Clin Endocrinol Metab2004;89:4963-71.
121. Maciver NJ, Jacobs SR, Wieman HL, Wofford JA, Coloff JL, RathmellJC. Glucose metabolism in lymphocytes is a regulated process with significant effects on immune cell function and survival. J LeukocBiol 2008;84:949-57.
122. Viardot A, Grey ST, Mackay F, Chisholm D. Potential anti inflammatory role of insulin via the preferential polarization of effector T cellstoward a T helper 2 phenotype. Endocrinology 2007;148:346-53.
123. La Cava A, Matarese G. The weight of leptin in immunity. Nat RevImmunol 2004;4:371-9.
124. Yang R, Barouch LA. Leptin signaling and obesity: cardio vascular consequences.Circ Res 2007;101:545-59.
125. Farooqi IS, Matarese G, Lord GM, Keogh JM, Lawrence E, Agwu C,Sanna V, Jebb SA, Perna F, Fontana S, et al. Beneficial effects of leptinon obesity, T cell hyporesponsiveness, and neuroendocrine/metabolicdys function of human congenital leptin deficiency. J Clin Invest 2002;110:1093-103.
126. Ouchi N, Walsh K. Adiponectin as an anti-inflammatory factor. Clin Chim Acta 2007;380:24-30.
127. Fantuzzi G. Adiponectin in inflammatory and immune-mediated diseases.Cytokine 2013;64:1-10.
128. Vucenik I, Stains JP. Obesity and cancer risk: evidence, mechanisms,and recommendations. Ann N Y Acad Sci 2012;1271:37-43.
129. Gajewski TF, Schreiber H, Fu YX. Innate and adaptive immune cells in the tumor micro environment. Nat Immunol 2013;14:1014-22.